http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
-
Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025
-
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
-
Cryoport opens 55,000-square-foot facility near Paris airport
-
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
-
Cryoport Reports Second Quarter 2025 Financial Results
-
Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025
-
Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers
-
Cryoport (CYRX) Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
-
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
-
Cryoport Reports First Quarter 2025 Financial Results
-
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025
-
Cryoport (CYRX) Sells CRYOPDP to DHL Group
-
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
-
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET
-
Cryoport (CYRX) launches MVE's High-Efficiency 800 C cryogenic freezer
-
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories
-
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
-
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
-
Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies
-
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
-
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
-
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
-
Cryoport Reports Third Quarter 2024 Financial Results
-
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
-
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
-
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
-
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
-
Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus
-
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
-
Cryoport Reports Second Quarter 2024 Financial Results
-
Cryoport (CYRX) Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
-
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
-
Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024
-
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
-
Cryoport Reports First Quarter 2024 Financial Results
-
Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
-
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
-
Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
-
Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services
-
Cryoport (CYRX) Announces Acquisition of Bluebird Express
-
Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express
-
Cryoport Reports Third Quarter 2023 Financial Results
-
Cryoport (CYRX) reports acquisition of Tec4med Lifescience GmbH
-
Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition
-
Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023
-
Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF
-
Cryoport (CYRX) and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies
-
Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies
-
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

